Cerep offers in vitro pharmacology, in vitro ADME-Tox and in vivo PK services, and provides solutions allowing faster and cost-effective drug discovery by identifying at early stages the most promising drug candidates as well as eliminating those compounds likely to fail in development. Cerep’s services benefit annually to about 500 pharmaceutical and biotechnological companies worldwide including most of the top pharmaceutical firms.
Celle Lévescault, FR
Size (employees)
178 (est)
Eurofins-Cerep is headquartered in Celle-Lévescault, FR

Eurofins-Cerep Office Locations

Eurofins-Cerep has offices in Celle-Lévescault, Saint Charles and Dundee Technology Park
Dundee Technology Park, GB
Gemini Cres Discovery House
Saint Charles, US
15 Research Park Dr
Show all (3)

Eurofins-Cerep Financials and Metrics

Eurofins-Cerep Financials


Market capitalization (25-Jul-2017)

25.2 m

Closing share price (25-Jul-2017)

Eurofins-Cerep's current market capitalization is €25.2 m.
Show all financial metrics

Eurofins-Cerep Market Value History

Eurofins-Cerep's Web-traffic and Trends

Eurofins-Cerep Company Life and Culture

You may also be interested in